Elevated leptin concentrations in growth hormone-deficient hypopituitary adults
- PMID: 9302387
- DOI: 10.1046/j.1365-2265.1997.2131054.x
Elevated leptin concentrations in growth hormone-deficient hypopituitary adults
Abstract
Background: Hypopituitarism with growth hormone (GH) deficiency is associated with obesity characterized by central (abdominal) distribution of fat. Recent work has demonstrated that leptin, a product of obese gene, is raised in obesity.
Objective: To study circulating leptin levels in GH-deficient hypopituitary adults and to investigate its anthropometric, gender and metabolic relations.
Methods: After an overnight fast of 10-12 hours, anthropometric parameters and body composition were measured and blood was collected for the measurement of circulating leptin, glucose, intact insulin, proinsulin, IGF-I, total cholesterol, triglycerides, high density lipoprotein (HDL) cholesterol and low density lipoprotein (LDL) cholesterol.
Subjects: Fifteen (7 men) GH-deficient hypopituitary adults (maximum stimulated serum GH to provocative testing < 6 mU/l) and 21 (10 men) normal control subjects matched for age, gender and body mass index (BMI).
Results: Fasting serum leptin was significantly higher in hypopituitary patients than controls (12.0 +/- 1.8 vs 8.0 +/- 1.5 micrograms/l, P = 0.04). The increase was more marked in obese (BMI > 26.0 kg/m2) patients compared with obese controls (15.3 +/- 2.0 vs 8.8 +/- 2.3 micrograms/l, P = 0.03) than in lean patients and controls. Obese control women and men had higher leptin levels than non-obese (women, 16.6 +/- 2.7 vs 8.6 +/- 0.6 micrograms/l, P = 0.03; men, 4.9 +/- 0.5 vs 2.9 +/- 0.6 micrograms/l, P = 0.035). Similar changes were observed for obese versus non-obese patients, although the changes did not reach statistical significance. Women in each group had significantly higher leptin concentrations than men (patients: 15.5 +/- 2.3 vs 7.3 +/- 1.4 micrograms/l, P = 0.009; controls: 12.6 +/- 2.4 vs 4.3 +/- 0.5 micrograms/l, P = 0.0001). These gender differences remained significant even when expressed in relation to BMI (patients: 0.57 +/- 0.09 vs 0.26 +/- 0.05 ng.m2/ml.kg, P = 0.009; controls: 0.43 +/- 0.05 vs 0.16 +/- 0.02 ng.m2/ml.kg, P = 0.0001). Serum leptin was positively associated with body mass index (P = 0.003), percentage body fat mass (P = 0.0001) and inversely related with age (P = 0.043). It demonstrated no relation with body weight, waist circumference, waist to hip ratio, fasting IGF-I, glucose, insulin, proinsulin, total cholesterol, triglycerides, HDL and LDL cholesterol in patients nor controls; 85% of variance in leptin was explained by a model including body mass index, gender, age and hypopituitarism.
Conclusions: Leptin concentrations are raised in GH-deficient hypopituitary adults to a greater extent than would be expected from the degree of obesity.
Comment in
-
Leptin--fat messenger or fat controller?Clin Endocrinol (Oxf). 1997 Aug;47(2):169-71. doi: 10.1046/j.1365-2265.1997.2931092.x. Clin Endocrinol (Oxf). 1997. PMID: 9302389 No abstract available.
Similar articles
-
Serum lipid and leptin concentrations in hypopituitary patients with growth hormone deficiency.Int J Obes Relat Metab Disord. 2000 May;24(5):619-26. doi: 10.1038/sj.ijo.0801206. Int J Obes Relat Metab Disord. 2000. PMID: 10849585
-
Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults.Clin Endocrinol (Oxf). 1995 Feb;42(2):179-89. doi: 10.1111/j.1365-2265.1995.tb01860.x. Clin Endocrinol (Oxf). 1995. PMID: 7704962
-
Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.Clin Endocrinol (Oxf). 2000 Oct;53(4):453-9. doi: 10.1046/j.1365-2265.2000.01108.x. Clin Endocrinol (Oxf). 2000. PMID: 11012570
-
Clinical aspects of leptin.Vitam Horm. 1998;54:1-30. doi: 10.1016/s0083-6729(08)60919-x. Vitam Horm. 1998. PMID: 9529971 Review.
-
Weight regulation, leptin and growth hormone.Horm Res. 1997;48 Suppl 5:116-21. doi: 10.1159/000191340. Horm Res. 1997. PMID: 9434056 Review.
Cited by
-
Potential for NPY receptor-related therapies for polycystic ovary syndrome: an updated review.Hormones (Athens). 2023 Sep;22(3):441-451. doi: 10.1007/s42000-023-00460-8. Epub 2023 Jul 14. Hormones (Athens). 2023. PMID: 37452264 Free PMC article. Review.
-
Presence of bovine leptin in edible commercial milk and infant formula.J Endocrinol Invest. 2002 Sep;25(8):670-4. doi: 10.1007/BF03345099. J Endocrinol Invest. 2002. PMID: 12240897
-
The association of leptin with dyslipidemia, arterial hypertension and obesity in Kyrgyz (Central Asian nation) population.BMC Res Notes. 2014 Jun 30;7:411. doi: 10.1186/1756-0500-7-411. BMC Res Notes. 2014. PMID: 24981337 Free PMC article.
-
Panhypopituitarism due to Absence of the Pituitary Stalk: A Rare Aetiology of Liver Cirrhosis.Case Rep Endocrinol. 2016;2016:9071097. doi: 10.1155/2016/9071097. Epub 2016 Apr 24. Case Rep Endocrinol. 2016. PMID: 27213061 Free PMC article.
-
Nonalcoholic Fatty liver disease and metabolic syndrome in hypopituitary patients.Am J Med Sci. 2009 Sep;338(3):190-5. doi: 10.1097/MAJ.0b013e3181a84bde. Am J Med Sci. 2009. PMID: 19745609 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials